(WDAY) Workday - Overview
Exchange: NASDAQ •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US98138H1014
Stock: Financial Management, Human Capital, Planning, Analytics
Total Rating 43
Risk 79
Buy Signal -0.31
| Risk 5d forecast | |
|---|---|
| Volatility | 37.2% |
| Relative Tail Risk | -13.3% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -1.48 |
| Alpha | -64.42 |
| Character TTM | |
|---|---|
| Beta | 0.893 |
| Beta Downside | 0.709 |
| Drawdowns 3y | |
|---|---|
| Max DD | 57.94% |
| CAGR/Max DD | -0.19 |
EPS (Earnings per Share)
Revenue
Description: WDAY Workday March 04, 2026
Workday, Inc. provides cloud-based enterprise software. Their offerings include financial management, spend management, and human capital management (HCM) applications. The company operates in the Application Software sector, which focuses on providing specialized software solutions to businesses.
Workday also offers planning, analytics, and reporting tools. They provide industry-specific solutions for healthcare (supply chain/inventory) and education (student/faculty lifecycle management). The companys business model relies on direct sales of its subscription-based cloud services.
To further analyze Workdays market position and financial health, consider exploring detailed reports on ValueRay.
Headlines to watch out for
- Subscription revenue growth fuels enterprise cloud application expansion
- New customer acquisition drives financial and HCM suite adoption
- Increased R&D investment impacts profitability margins
- Competition in cloud software market pressures pricing
- Global economic slowdown could reduce enterprise IT spending
Piotroski VR‑10 (Strict, 0-10) 9.0
| Net Income: 693.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.15 > 0.02 and ΔFCF/TA 3.18 > 1.0 |
| NWC/Revenue: 21.47% < 20% (prev 56.00%; Δ -34.53% < -1%) |
| CFO/TA 0.16 > 3% & CFO 2.94b > Net Income 693.0m |
| Net Debt (2.32b) to EBITDA (1.44b): 1.61 < 3 |
| Current Ratio: 1.32 > 1.5 & < 3 |
| Outstanding Shares: last quarter (263.4m) vs 12m ago -2.44% < -2% |
| Gross Margin: 75.70% > 18% (prev 0.76%; Δ 7.49k% > 0.5%) |
| Asset Turnover: 52.99% > 50% (prev 46.98%; Δ 6.01% > 0%) |
| Interest Coverage Ratio: 9.53 > 6 (EBITDA TTM 1.44b / Interest Expense TTM 115.0m) |
Altman Z'' 0.99
| A: 0.11 (Total Current Assets 8.43b - Total Current Liabilities 6.38b) / Total Assets 18.07b |
| B: -0.03 (Retained Earnings -512.0m / Total Assets 18.07b) |
| C: 0.06 (EBIT TTM 1.10b / Avg Total Assets 18.03b) |
| D: -0.06 (Book Value of Equity -648.0m / Total Liabilities 10.27b) |
| Altman-Z'' Score: 0.99 = BB |
Beneish M -2.88
| DSRI: 1.03 (Receivables 2.33b/2.00b, Revenue 9.55b/8.45b) |
| GMI: 1.00 (GM 75.70% / 75.50%) |
| AQI: 1.27 (AQ_t 0.43 / AQ_t-1 0.34) |
| SGI: 1.13 (Revenue 9.55b / 8.45b) |
| TATA: -0.12 (NI 693.0m - CFO 2.94b) / TA 18.07b) |
| Beneish M-Score: -2.88 (Cap -4..+1) = A |
What is the price of WDAY shares?
As of March 17, 2026, the stock is trading at USD 133.63 with a total of 6,331,197 shares traded.
Over the past week, the price has changed by -9.79%, over one month by -6.63%, over three months by -38.17% and over the past year by -46.68%.
Over the past week, the price has changed by -9.79%, over one month by -6.63%, over three months by -38.17% and over the past year by -46.68%.
Is WDAY a buy, sell or hold?
Workday has received a consensus analysts rating of 4.21.
Therefore, it is recommended to buy WDAY.
- StrongBuy: 20
- Buy: 12
- Hold: 11
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the WDAY price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 183.2 | 37.1% |
| Analysts Target Price | 183.2 | 37.1% |
WDAY Fundamental Data Overview March 14, 2026
P/E Trailing = 51.1885
P/E Forward = 12.4224
P/S = 3.7202
P/B = 4.52
P/EG = 0.5111
Revenue TTM = 9.55b USD
EBIT TTM = 1.10b USD
EBITDA TTM = 1.44b USD
Long Term Debt = 2.99b USD (from longTermDebt, two quarters ago)
Short Term Debt = 130.0m USD (from shortTermDebt, last quarter)
Debt = 3.82b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 2.32b USD (from netDebt column, last quarter)
Enterprise Value = 33.91b USD (35.54b + Debt 3.82b - CCE 5.44b)
Interest Coverage Ratio = 9.53 (Ebit TTM 1.10b / Interest Expense TTM 115.0m)
EV/FCF = 12.21x (Enterprise Value 33.91b / FCF TTM 2.78b)
FCF Yield = 8.19% (FCF TTM 2.78b / Enterprise Value 33.91b)
FCF Margin = 29.07% (FCF TTM 2.78b / Revenue TTM 9.55b)
Net Margin = 7.26% (Net Income TTM 693.0m / Revenue TTM 9.55b)
Gross Margin = 75.70% ((Revenue TTM 9.55b - Cost of Revenue TTM 2.32b) / Revenue TTM)
Gross Margin QoQ = 75.87% (prev 75.70%)
Tobins Q-Ratio = 1.88 (Enterprise Value 33.91b / Total Assets 18.07b)
Interest Expense / Debt = 0.73% (Interest Expense 28.0m / Debt 3.82b)
Taxrate = 45.08% (119.0m / 264.0m)
NOPAT = 602.0m (EBIT 1.10b * (1 - 45.08%))
Current Ratio = 1.32 (Total Current Assets 8.43b / Total Current Liabilities 6.38b)
Debt / Equity = 0.49 (Debt 3.82b / totalStockholderEquity, last quarter 7.80b)
Debt / EBITDA = 1.61 (Net Debt 2.32b / EBITDA 1.44b)
Debt / FCF = 0.84 (Net Debt 2.32b / FCF TTM 2.78b)
Total Stockholder Equity = 8.69b (last 4 quarters mean from totalStockholderEquity)
RoA = 3.84% (Net Income 693.0m / Total Assets 18.07b)
RoE = 7.97% (Net Income TTM 693.0m / Total Stockholder Equity 8.69b)
RoCE = 9.38% (EBIT 1.10b / Capital Employed (Equity 8.69b + L.T.Debt 2.99b))
RoIC = 5.03% (NOPAT 602.0m / Invested Capital 11.98b)
WACC = 8.35% (E(35.54b)/V(39.36b) * Re(9.20%) + D(3.82b)/V(39.36b) * Rd(0.73%) * (1-Tc(0.45)))
Discount Rate = 9.20% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -0.96%
[DCF] Terminal Value 80.14% ; FCFF base≈2.54b ; Y1≈3.14b ; Y5≈5.34b
[DCF] Fair Price = 385.1 (EV 84.34b - Net Debt 2.32b = Equity 82.02b / Shares 213.0m; r=8.35% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: 97.52 | EPS CAGR: 33.75% | SUE: 3.54 | # QB: 12
Revenue Correlation: 99.60 | Revenue CAGR: 16.36% | SUE: 0.96 | # QB: 2
EPS next Quarter (2026-04-30): EPS=2.51 | Chg7d=+0.002 | Chg30d=-0.016 | Revisions Net=+1 | Analysts=37
EPS current Year (2027-01-31): EPS=10.52 | Chg7d=+0.003 | Chg30d=-0.217 | Revisions Net=-18 | Growth EPS=+14.0% | Growth Revenue=+11.7%
EPS next Year (2028-01-31): EPS=12.46 | Chg7d=-0.014 | Chg30d=-0.589 | Revisions Net=-22 | Growth EPS=+18.4% | Growth Revenue=+11.2%
[Analyst] Revisions Ratio: +0.03 (16 Up / 15 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 7.2% (Discount Rate 9.2% - Earnings Yield 2.0%)
[Growth] Growth Spread = +5.1% (Analyst 12.3% - Implied 7.2%)
P/E Forward = 12.4224
P/S = 3.7202
P/B = 4.52
P/EG = 0.5111
Revenue TTM = 9.55b USD
EBIT TTM = 1.10b USD
EBITDA TTM = 1.44b USD
Long Term Debt = 2.99b USD (from longTermDebt, two quarters ago)
Short Term Debt = 130.0m USD (from shortTermDebt, last quarter)
Debt = 3.82b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 2.32b USD (from netDebt column, last quarter)
Enterprise Value = 33.91b USD (35.54b + Debt 3.82b - CCE 5.44b)
Interest Coverage Ratio = 9.53 (Ebit TTM 1.10b / Interest Expense TTM 115.0m)
EV/FCF = 12.21x (Enterprise Value 33.91b / FCF TTM 2.78b)
FCF Yield = 8.19% (FCF TTM 2.78b / Enterprise Value 33.91b)
FCF Margin = 29.07% (FCF TTM 2.78b / Revenue TTM 9.55b)
Net Margin = 7.26% (Net Income TTM 693.0m / Revenue TTM 9.55b)
Gross Margin = 75.70% ((Revenue TTM 9.55b - Cost of Revenue TTM 2.32b) / Revenue TTM)
Gross Margin QoQ = 75.87% (prev 75.70%)
Tobins Q-Ratio = 1.88 (Enterprise Value 33.91b / Total Assets 18.07b)
Interest Expense / Debt = 0.73% (Interest Expense 28.0m / Debt 3.82b)
Taxrate = 45.08% (119.0m / 264.0m)
NOPAT = 602.0m (EBIT 1.10b * (1 - 45.08%))
Current Ratio = 1.32 (Total Current Assets 8.43b / Total Current Liabilities 6.38b)
Debt / Equity = 0.49 (Debt 3.82b / totalStockholderEquity, last quarter 7.80b)
Debt / EBITDA = 1.61 (Net Debt 2.32b / EBITDA 1.44b)
Debt / FCF = 0.84 (Net Debt 2.32b / FCF TTM 2.78b)
Total Stockholder Equity = 8.69b (last 4 quarters mean from totalStockholderEquity)
RoA = 3.84% (Net Income 693.0m / Total Assets 18.07b)
RoE = 7.97% (Net Income TTM 693.0m / Total Stockholder Equity 8.69b)
RoCE = 9.38% (EBIT 1.10b / Capital Employed (Equity 8.69b + L.T.Debt 2.99b))
RoIC = 5.03% (NOPAT 602.0m / Invested Capital 11.98b)
WACC = 8.35% (E(35.54b)/V(39.36b) * Re(9.20%) + D(3.82b)/V(39.36b) * Rd(0.73%) * (1-Tc(0.45)))
Discount Rate = 9.20% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -0.96%
[DCF] Terminal Value 80.14% ; FCFF base≈2.54b ; Y1≈3.14b ; Y5≈5.34b
[DCF] Fair Price = 385.1 (EV 84.34b - Net Debt 2.32b = Equity 82.02b / Shares 213.0m; r=8.35% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: 97.52 | EPS CAGR: 33.75% | SUE: 3.54 | # QB: 12
Revenue Correlation: 99.60 | Revenue CAGR: 16.36% | SUE: 0.96 | # QB: 2
EPS next Quarter (2026-04-30): EPS=2.51 | Chg7d=+0.002 | Chg30d=-0.016 | Revisions Net=+1 | Analysts=37
EPS current Year (2027-01-31): EPS=10.52 | Chg7d=+0.003 | Chg30d=-0.217 | Revisions Net=-18 | Growth EPS=+14.0% | Growth Revenue=+11.7%
EPS next Year (2028-01-31): EPS=12.46 | Chg7d=-0.014 | Chg30d=-0.589 | Revisions Net=-22 | Growth EPS=+18.4% | Growth Revenue=+11.2%
[Analyst] Revisions Ratio: +0.03 (16 Up / 15 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 7.2% (Discount Rate 9.2% - Earnings Yield 2.0%)
[Growth] Growth Spread = +5.1% (Analyst 12.3% - Implied 7.2%)